Part B

Displaying 1041 - 1050 of 1634

New high-cost cell-based gene therapy drug Encelto approved for use in the ambulatory surgical center (ASC) setting

Medicare approved the groundbreaking new cell-based gene therapy drug, Encelto, for use in the ambulatory surgical center setting, effective for claims with dates of service on or after October 1,…

E/M: Reviewing amount and/or complexity of data

For the element of medical decision making addressing the amount and/or complexity of data to be reviewed and analyzed, the AMA Levels of Medical Decision Making table indicates: "Each unique test,…

E/M: Reviewing amount and/or complexity of data

For the element of medical decision making addressing the amount and/or complexity of data to be reviewed and analyzed, the AMA Levels of Medical Decision Making table indicates: "Each unique test,…

SPOT testimonials

Read these testimonials from SPOT users.

SPOT testimonials

Read these testimonials from SPOT users.

Proposed 2026 Medicare allowances for portable x-ray transportation codes

Reminder: The preliminary 2026 portable x-ray transportation payment rates have been posted for notice. The comment period is now closed.

MLN Connects Special Edition for November 7, 2025

View this special edition update on processing of telehealth and acute hospital care at home claims.

MLN Connects Special Edition for November 7, 2025

View this special edition update on processing of telehealth and acute hospital care at home claims.

Core-based statistical areas for ASCs - Florida

Beginning in 2008, CMS adjusts ASC rates for geographic differences in wages using the geographic locality definitions initially established in 2003 by the Office of Management and Budget (OMB).

MLN Connects Special Edition for November 3, 2025

View this special edition on recent CMS actions.